Suven Life Sciences rises 5% on product patents in Eurasia Norway News News / News 6 years ago 449 Views comments The patents are for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2034 and 2026 respective... Read more
News Monsoon Session: Opposition attacks govt for its 'failure' to address farm issues News / News - 6 years ago
News Xiaomiâs Redmi 4A does a record high flash sale: Deal 100% claimed within minutes News / News - 6 years ago
Comments